H2020FP7HORIZONEDF
Hospices Civils de Lyon
- Country
- FRFrance
- Defence projects
- 1
- Projects, all programmes
- 42
- As coordinator
- 3
- EU contribution (CORDIS)
- EUR 9,228,168
- Active
- 2008 to 2025
Projects
42 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| HAP2Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia | H2020 | 2020 | Participant | EUR 440,228 |
| TopSurgeonsUnderstanding the influence of human and organizational factors on surgeon performance to enhance patient outcomes: experimental evaluation of a customized coaching program | H2020 | 2019 | Third party | Not stated |
| ConcePTIONBuilding an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation | H2020 | 2019 | Third party | Not stated |
| CARDIATEAMCARdiomyopathy in type 2 DIAbetes mellitus | H2020 | 2019 | Participant | EUR 202,709 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 45,333 |
| TENSIONEfficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial | H2020 | 2018 | Participant | EUR 237,654 |
| MEDIT-AGEINGInvestigating the impact of meditation training on mental health and wellbeing in the ageing population | H2020 | 2016 | Participant | EUR 100,500 |
| RESSTOREREgenerative Stem cell therapy for STroke in Europe | H2020 | 2015 | Participant | EUR 70,000 |
| I-MOVE-plusI-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | H2020 | 2015 | Participant | EUR 80,723 |
| IABC PROGRAMMEiABC Programme | FP7 | 2015 | Participant | EUR 9,057 |
| CFMATTERSCystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. | FP7 | 2013 | Participant | EUR 82,341 |
| ELIMOXBiopharmaceutical therapy for treatment of Primary Hyperoxaluria | FP7 | 2013 | Participant | EUR 5,040 |
| DSD-LIFEClinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) | FP7 | 2012 | Participant | EUR 99,868 |
| WAKE-UPEfficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial | FP7 | 2011 | Participant | EUR 861,767 |
| THROMBUSA quantitative model of thrombosis in intracranial aneurysms | FP7 | 2011 | Participant | EUR 83,783 |
| ALPHA-MANClinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme | FP7 | 2010 | Participant | EUR 255,561 |
| SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for Medicines | FP7 | 2010 | Participant | EUR 26,027 |
| ENCE-CF-LAM-LTXEuropean Networks of Centres of Expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation) | FP7 | 2009 | Participant | EUR 42,844 |
| MITOTARGETMitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics | FP7 | 2009 | Participant | EUR 98,258 |
| EURIPIDESEUropean Research initiative to develop Imaging Probes for early In-vivo Diagnosis and Evaluation of response to therapeutic Substances | FP7 | 2008 | Participant | EUR 167,600 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
- European Defence Fund: project factsheets of the call resultsLast read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: European Commission, DG DEFIS, EDF results factsheets.European Defence Fund participants are read from the project factsheets that DG DEFIS publishes, by a language model; every name is checked against the factsheet text and a name that is not in it is dropped. The factsheets state no amount per participant.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.